Evidence map›Paper›PMID 28255983›Full record

ArticleThe Journal of physiology2017

Vasopressin V1a receptors mediate the hypertensive effects of [Pyr

Philip R Griffiths, Stephen J Lolait, Louise E Harris, Julian F R Paton, Anne-Marie O'Carroll

Open access · hybridAbstract read
In one paragraph

Article in The Journal of physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Complementary Role of Oxytocin and Vasopressin in Cardiovascular Regulation.International journal of molecular sciences · 2021
    Review
  5. Novel Targets for Hypertension Drug Discovery.Current hypertension reports · 2021
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Apelinergic System Structure and Function.Comprehensive Physiology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Philip R GriffithsSchool of Clinical Sciences, University of Bristol, Bristol, UK.
Stephen J LolaitSchool of Clinical Sciences, University of Bristol, Bristol, UK.
Louise E HarrisSchool of Clinical Sciences, University of Bristol, Bristol, UK.
Julian F R PatonSchool of Physiology, Pharmacology and Neuroscience, Biomedical Sciences, University of Bristol, Bristol, UK.
Anne-Marie O'CarrollSchool of Clinical Sciences, University of Bristol, Bristol, UK.ORCID 0000-0001-5255-8506
University of Bristol · GB

Funding

British Heart Foundation PG/12/23/29475British Heart Foundation PG/15/14/31311British Heart Foundation RG/12/6/29670
6 · The paper itself

Abstract

key pointsDysfunctions in CNS regulation of arterial blood pressure lead to an increase in sympathetic nerve activity that participates in the pathogenesis of hypertension. The apelin-apelin receptor system affects arterial blood pressure homeostasis; however, the central mechanisms underlying apelin-mediated changes in sympathetic nerve activity and blood pressure have not been clarified. We explored the mechanisms involved in the regulation of [Pyr ABSTRACT: Apelin is a ubiquitous peptide that can elevate arterial blood pressure (ABP) yet understanding of the mechanisms involved remain incomplete. Bilateral microinjection of [Pyr

Indexed as

AnimalsAntidiuretic Hormone Receptor AntagonistsApelin ReceptorsBlood PressureHypertensionIntercellular Signaling Peptides and ProteinsMaleMedulla OblongataRatsRats, WistarReceptors, VasopressinAntidiuretic Hormone Receptor Antagonistsapelin 13, Pyr(1)-Apelin ReceptorsIntercellular Signaling Peptides and ProteinsReceptors, VasopressinapelinAPJblood pressurerostral ventrolateral medullasympathetic nervous systemvasopressin

Identifiers

PMID28255983
PMCPMC5451710
OpenAlexW2593747218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.